StonvexLoading…
StonvexStonvexStonvexCore line items from TBPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $17.70M | $107.46M | $19.99M | $26.20M |
Operating Income | $-9.48M | $-3.60M | $-6.46M | $-2.73M |
Net Income | $-4.93M | $105.89M | $3.62M | $54.84M |
EPS (Diluted) | $-0.10 | $2.06 | $0.07 | $1.08 |
Total Assets | $472.31M | $485.57M | $415.46M | $426.04M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $288.10M | $167.81M | $174.77M | $281.93M |
Free Cash Flow OCF − CapEx | Not available | $238.50M | $244.57M | $251.08M |
Shares Outstanding | 51.52M | 51.07M | 50.67M | 50.36M |